|Other Accession||P11167, P13355, P20303, P17809, P46896, P27674, NP_006507.2, P79365|
|Other Names||Solute carrier family 2, facilitated glucose transporter member 1, Glucose transporter type 1, erythrocyte/brain, GLUT-1, HepG2 glucose transporter, SLC2A1, GLUT1|
|Target/Specificity||The synthetic peptide sequence is selected from aa 453-464 of HUMAN SLC2A1|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Facilitative glucose transporter. This isoform may be responsible for constitutive or basal glucose uptake. Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses.|
|Cellular Location||Cell membrane; Multi-pass membrane protein. Melanosome. Note=Localizes primarily at the cell surface Identified by mass spectrometry in melanosome fractions from stage I to stage IV|
|Tissue Location||Detected in erythrocytes (at protein level). Expressed at variable levels in many human tissues|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
This gene encodes a major glucose transporter in the mammalian blood-brain barrier. Mutations in this gene have been found in a family with paroxysmal exertion-induced dyskinesia.
Mullen, S.A., et al. Neurology 75(5):432-440(2010)
Grabellus, F., et al. J. Nucl. Med. 51(8):1191-1197(2010)
Koda, M., et al. BMC Cancer 10, 320 (2010) :
Kim, S.J., et al. J. Exp. Clin. Cancer Res. 29, 69 (2010) :
Xiong, Y., et al. Eur. J. Gynaecol. Oncol. 31(2):160-164(2010)
If you have any additional inquiries please email technical services at email@example.com.